Defendant Name:
Adam C. Derbyshire
Defendant Type:
Individual
Initial Case Details
Legal Case Name
SEC v. Adam C. Derbyshire
First Document Date
28-Sep-2018
Initial Filing Format
Civil Proceeding
Case Number
18-cv-08891
Allegation Type
Issuer Reporting and Disclosure
Federal District Court
New York, Southern District of New York
Affiliations
- Former: CFO at Salix Pharmaceuticals, Ltd.
Related Violations Alleged
Adam C. Derbyshire is alleged to have aided and abetted Salix Pharmaceuticals, Ltd.'s violation of Sec 13(a) of the Exchange Act.
Adam C. Derbyshire is alleged to have aided and abetted an unidentified individual or entity's violation of Sec 13(a) of the Exchange Act.
Adam C. Derbyshire is alleged to have aided and abetted Salix Pharmaceuticals, Ltd.'s violation of Rule 13a-13 of the Exchange Act.
Adam C. Derbyshire is alleged to have aided and abetted an unidentified individual or entity's violation of Rule 13a-13 of the Exchange Act.
Resolutions
Bars:
- Bar from acting as Director or Officer of a public company for 5 years
First Resolution Date
04-Apr-2019
Headline Total Penalty and Disgorgement
$1,053,371
